Literature DB >> 5340248

Motor responses of the urinary bladder and skeletal muscle in botulinum intoxicated rats.

F G Carpenter.   

Abstract

1. Type A or type D botulinum toxin administered to rats did not produce a generalized paralysis of skeletal muscles at the time of ventilatory arrest. However, if survival was extended by artificial ventilation complete blockade of neuromuscular transmission developed 6.5 hr after 100 MLD of type D and 5 hr after 1000 MLD of type A toxin. The onset of paralysis of a muscle was shortened by repetitive stimulation of the motor nerves.2. There was no consistent blockade of parasympathetically innervated viscera in animals dying after type A toxin. Animals given type D toxin displayed mydriasis and urinary retention before death.3. Motor responses to electrical stimulation, of bladder preparations in vitro were more vulnerable to type D than to type A toxin. When somatic paralysis was complete in animals treated with type A or type D toxin the excised bladders produced pressure elevations 45 and 25%, respectively, of control preparations.4. During electrical stimulation of bladder preparations nearly paralysed by either toxin, the ACh release was significantly diminished from controls. In the rat bladder botulinum toxin specifically disrupted the liberation of mediator from post-ganglionic nerve endings.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5340248      PMCID: PMC1395994          DOI: 10.1113/jphysiol.1967.sp008119

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  10 in total

1.  INTERACTION BETWEEN CO2 AND CITRATE IONS IN MEDULLARY RETICULAR FORMATION.

Authors:  K E DEHAVEN; F G CARPENTER
Journal:  Am J Physiol       Date:  1964-08

2.  Excitation of rat urinary bladder by coaxial electrodes and by chemical agents.

Authors:  F G CARPENTER
Journal:  Am J Physiol       Date:  1963-04

3.  Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin.

Authors:  R HUGHES; B C WHALER
Journal:  J Physiol       Date:  1962-02       Impact factor: 5.182

4.  Body weight as a factor in the response of mice to botulinal toxins.

Authors:  C LAMANNA; W I JENSEN; I D BROSS
Journal:  Am J Hyg       Date:  1955-07

5.  An intracellular study of the action of repetitive nerve volleys and of botulinum toxin on miniature end-plate potentials.

Authors:  V B BROOKS
Journal:  J Physiol       Date:  1956-11-28       Impact factor: 5.182

6.  The use and limitations of atropine for pharmacological studies on autonomic effectors.

Authors:  N AMBACHE
Journal:  Pharmacol Rev       Date:  1955-12       Impact factor: 25.468

7.  The action of botulinum toxin on motor-nerve filaments.

Authors:  V B BROOKS
Journal:  J Physiol       Date:  1954-03-29       Impact factor: 5.182

8.  A further survey of the action of Clostridium botulinum toxin upon different types of autonomic nerve fibre.

Authors:  N AMBACHE
Journal:  J Physiol       Date:  1951-03       Impact factor: 5.182

9.  The action of botulinum toxin on the neuro-muscular junction.

Authors:  A S V BURGEN; F DICKENS; L J ZATMAN
Journal:  J Physiol       Date:  1949-08       Impact factor: 5.182

10.  Relation of acetylcholine release to responses of the rat urinary bladder.

Authors:  F G Carpenter; S A Rand
Journal:  J Physiol       Date:  1965-09       Impact factor: 5.182

  10 in total
  11 in total

1.  Botulinum toxin: poisoning the spastic bladder and urethra.

Authors:  Christopher P Smith; George T Somogyi; Michael B Chancellor
Journal:  Rev Urol       Date:  2002

2.  Characterizing the Bladder's Response to Onabotulinum Toxin Type A Using a Rat Model.

Authors:  Alexis A Dieter; Jennifer M Wu; Nazema Y Siddiqui; Danielle J Degoski; Jillene M Brooks; Paul C Dolber; Matthew O Fraser
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Nov/Dec       Impact factor: 2.091

3.  [Treatment of botulism with guanidine].

Authors:  K Ricker; W Döll
Journal:  Z Neurol       Date:  1970

4.  Botulism: clinical neurophysical findings.

Authors:  R Hagenah; A Müller-Jensen
Journal:  J Neurol       Date:  1978-02-14       Impact factor: 4.849

5.  Blockade by tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus.

Authors:  H Bigalke; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-07       Impact factor: 3.000

Review 6.  Botulinum Toxin Treatment in Multiple Sclerosis-a Review.

Authors:  Yasaman Safarpour; Tahereh Mousavi; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2017-08-17       Impact factor: 3.598

Review 7.  Botulinum toxin for the management of bladder dysfunction.

Authors:  Brigitte Schurch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  Atropine resistance and muscarinic receptors in the rat urinary bladder.

Authors:  F G Carpenter
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

9.  The effect of type D botulinum toxin on frog neuromuscular junctions.

Authors:  A J Harris; R Miledi
Journal:  J Physiol       Date:  1971-09       Impact factor: 5.182

10.  Potentiation of nerve-induced bladder responses by tetraethylammonium in relation to junctional and extrajunctional muscarinic receptors.

Authors:  F G Carpenter
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.